Close Menu

NEW YORK – Massachusetts General Hospital, the Infectious Disease Diagnostics Laboratory at Children's Hospital of Philadelphia (CHOP), and the Diagnostic Molecular Laboratory at Northwestern Medicine, have received Emergency Use Authorization from the US Food and Drug Administration for tests to detect SARS-CoV-2.

All three organization's real-time RT-PCR tests were cleared by the FDA last week for detecting  SARS-CoV-2 using nasopharyngeal swabs, nasal swabs, and bronchoalveolar lavage specimens.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.